| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 67 | 2026 | 246 | 17.270 |
Why?
|
| Endovascular Procedures | 60 | 2026 | 399 | 15.610 |
Why?
|
| Aortic Aneurysm, Abdominal | 45 | 2026 | 125 | 13.790 |
Why?
|
| Blood Vessel Prosthesis | 51 | 2026 | 255 | 10.250 |
Why?
|
| Stents | 46 | 2026 | 433 | 7.920 |
Why?
|
| Aortic Aneurysm, Thoracic | 23 | 2025 | 101 | 5.580 |
Why?
|
| Prosthesis Design | 34 | 2026 | 308 | 4.220 |
Why?
|
| Endoleak | 23 | 2026 | 45 | 4.150 |
Why?
|
| Aortic Rupture | 14 | 2024 | 53 | 4.100 |
Why?
|
| Aortic Aneurysm | 9 | 2026 | 72 | 3.480 |
Why?
|
| Iliac Aneurysm | 7 | 2024 | 9 | 2.800 |
Why?
|
| Iliac Artery | 7 | 2026 | 44 | 2.480 |
Why?
|
| Vascular Surgical Procedures | 9 | 2026 | 166 | 2.450 |
Why?
|
| Treatment Outcome | 65 | 2026 | 9711 | 2.310 |
Why?
|
| Venous Thrombosis | 6 | 2021 | 264 | 1.920 |
Why?
|
| Registries | 23 | 2026 | 1122 | 1.910 |
Why?
|
| Risk Factors | 43 | 2026 | 6233 | 1.890 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2023 | 74 | 1.890 |
Why?
|
| Aorta, Thoracic | 16 | 2026 | 154 | 1.870 |
Why?
|
| Aortic Diseases | 8 | 2024 | 88 | 1.770 |
Why?
|
| Aorta | 8 | 2024 | 275 | 1.510 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2024 | 107 | 1.510 |
Why?
|
| Postoperative Complications | 26 | 2026 | 2681 | 1.360 |
Why?
|
| Time Factors | 33 | 2026 | 5567 | 1.320 |
Why?
|
| Humans | 123 | 2026 | 98088 | 1.320 |
Why?
|
| Retrospective Studies | 41 | 2026 | 10973 | 1.300 |
Why?
|
| Models, Cardiovascular | 5 | 2025 | 96 | 1.240 |
Why?
|
| Femoral Artery | 3 | 2025 | 96 | 1.240 |
Why?
|
| Aged | 55 | 2026 | 21758 | 1.130 |
Why?
|
| Aged, 80 and over | 33 | 2026 | 7389 | 1.120 |
Why?
|
| Prosthesis Failure | 9 | 2024 | 117 | 1.070 |
Why?
|
| Vena Cava, Inferior | 3 | 2022 | 140 | 1.050 |
Why?
|
| Ultrasonography, Doppler, Duplex | 4 | 2020 | 42 | 0.950 |
Why?
|
| Vascular Diseases | 2 | 2020 | 120 | 0.920 |
Why?
|
| Male | 68 | 2026 | 47077 | 0.910 |
Why?
|
| Lower Extremity | 3 | 2026 | 108 | 0.910 |
Why?
|
| Dissection | 1 | 2025 | 48 | 0.890 |
Why?
|
| Catheterization, Peripheral | 4 | 2020 | 62 | 0.880 |
Why?
|
| Risk Assessment | 23 | 2026 | 2585 | 0.870 |
Why?
|
| Patient-Specific Modeling | 3 | 2025 | 25 | 0.870 |
Why?
|
| Anastomosis, Surgical | 2 | 2025 | 289 | 0.860 |
Why?
|
| Lost to Follow-Up | 1 | 2024 | 17 | 0.820 |
Why?
|
| Aorta, Abdominal | 5 | 2021 | 57 | 0.810 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2023 | 189 | 0.780 |
Why?
|
| Female | 59 | 2026 | 51541 | 0.780 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 342 | 0.770 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 338 | 0.770 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 132 | 0.720 |
Why?
|
| Endarterectomy, Carotid | 3 | 2020 | 74 | 0.720 |
Why?
|
| Vascular Patency | 6 | 2024 | 123 | 0.710 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2020 | 7 | 0.660 |
Why?
|
| Kidney Pelvis | 1 | 2021 | 46 | 0.650 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2012 | 56 | 0.650 |
Why?
|
| Carotid Stenosis | 2 | 2020 | 116 | 0.650 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 31 | 0.640 |
Why?
|
| Angioplasty | 4 | 2006 | 68 | 0.640 |
Why?
|
| Situs Inversus | 1 | 2020 | 16 | 0.640 |
Why?
|
| Carotid Artery, Internal | 1 | 2020 | 74 | 0.640 |
Why?
|
| Education, Medical | 1 | 2023 | 229 | 0.630 |
Why?
|
| Jehovah's Witnesses | 1 | 2020 | 21 | 0.630 |
Why?
|
| Collateral Circulation | 1 | 2020 | 37 | 0.630 |
Why?
|
| Prosthesis-Related Infections | 3 | 2021 | 62 | 0.620 |
Why?
|
| Leg | 3 | 2013 | 145 | 0.620 |
Why?
|
| Upper Extremity | 1 | 2020 | 69 | 0.610 |
Why?
|
| Aortography | 10 | 2025 | 60 | 0.610 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2020 | 100 | 0.610 |
Why?
|
| Betacoronavirus | 4 | 2020 | 287 | 0.590 |
Why?
|
| Middle Aged | 39 | 2026 | 29428 | 0.590 |
Why?
|
| Renal Dialysis | 3 | 2023 | 357 | 0.570 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 411 | 0.570 |
Why?
|
| Terminology as Topic | 2 | 2023 | 225 | 0.560 |
Why?
|
| Kidney Diseases | 1 | 2021 | 314 | 0.550 |
Why?
|
| Iliac Vein | 2 | 2010 | 32 | 0.540 |
Why?
|
| Reoperation | 8 | 2026 | 727 | 0.540 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 1129 | 0.520 |
Why?
|
| Physicians | 2 | 2021 | 685 | 0.510 |
Why?
|
| Finite Element Analysis | 5 | 2025 | 79 | 0.500 |
Why?
|
| Computed Tomography Angiography | 7 | 2025 | 188 | 0.500 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 320 | 0.500 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2013 | 659 | 0.480 |
Why?
|
| Device Removal | 2 | 2021 | 170 | 0.460 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 387 | 0.460 |
Why?
|
| Aneurysm, Infected | 3 | 2010 | 14 | 0.460 |
Why?
|
| Patient Transfer | 1 | 2016 | 113 | 0.440 |
Why?
|
| Aneurysm | 2 | 2015 | 59 | 0.440 |
Why?
|
| Aneurysm, Ruptured | 3 | 2020 | 80 | 0.420 |
Why?
|
| Surgery Department, Hospital | 3 | 2020 | 44 | 0.410 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2020 | 92 | 0.400 |
Why?
|
| Leg Ulcer | 1 | 2012 | 7 | 0.380 |
Why?
|
| Embolic Protection Devices | 1 | 2012 | 9 | 0.370 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 40 | 0.370 |
Why?
|
| Heparin | 1 | 2013 | 182 | 0.360 |
Why?
|
| Anticoagulants | 2 | 2013 | 486 | 0.360 |
Why?
|
| Embolism | 1 | 2012 | 32 | 0.360 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 539 | 0.360 |
Why?
|
| Transducers, Pressure | 3 | 2011 | 6 | 0.360 |
Why?
|
| Pandemics | 5 | 2020 | 916 | 0.360 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 88 | 0.360 |
Why?
|
| Limb Salvage | 1 | 2012 | 43 | 0.350 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 102 | 0.350 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 480 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 2666 | 0.340 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2011 | 9 | 0.340 |
Why?
|
| United States | 12 | 2023 | 8197 | 0.340 |
Why?
|
| Predictive Value of Tests | 5 | 2024 | 1782 | 0.330 |
Why?
|
| Monitoring, Ambulatory | 1 | 2011 | 32 | 0.330 |
Why?
|
| Septal Occluder Device | 1 | 2011 | 52 | 0.320 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 62 | 0.320 |
Why?
|
| Carotid Artery Diseases | 1 | 2011 | 101 | 0.310 |
Why?
|
| Bicycling | 1 | 2010 | 21 | 0.310 |
Why?
|
| Cerebrovascular Disorders | 1 | 2011 | 139 | 0.310 |
Why?
|
| Stroke | 5 | 2023 | 1154 | 0.290 |
Why?
|
| Sex Factors | 5 | 2020 | 1138 | 0.290 |
Why?
|
| Foreign-Body Migration | 2 | 2024 | 32 | 0.290 |
Why?
|
| Health Status Disparities | 2 | 2023 | 234 | 0.280 |
Why?
|
| Balloon Occlusion | 2 | 2005 | 29 | 0.280 |
Why?
|
| Subclavian Artery | 4 | 2021 | 43 | 0.270 |
Why?
|
| Consensus | 3 | 2024 | 315 | 0.270 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 445 | 0.260 |
Why?
|
| Fibrinolytic Agents | 4 | 2011 | 242 | 0.260 |
Why?
|
| Diverticulum | 2 | 2020 | 45 | 0.250 |
Why?
|
| Multiple Trauma | 2 | 2006 | 40 | 0.250 |
Why?
|
| Groin | 2 | 2025 | 11 | 0.250 |
Why?
|
| Nephrectomy | 1 | 2009 | 290 | 0.250 |
Why?
|
| Vascular Fistula | 2 | 2020 | 12 | 0.240 |
Why?
|
| Telemetry | 1 | 2006 | 30 | 0.240 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 469 | 0.240 |
Why?
|
| Lipoprotein(a) | 1 | 2026 | 33 | 0.240 |
Why?
|
| Deglutition Disorders | 2 | 2020 | 126 | 0.240 |
Why?
|
| Ischemia | 2 | 2007 | 262 | 0.230 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2006 | 119 | 0.230 |
Why?
|
| Aneurysm, False | 2 | 2010 | 52 | 0.230 |
Why?
|
| Incidence | 3 | 2020 | 1779 | 0.220 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2025 | 7 | 0.220 |
Why?
|
| Cadaver | 1 | 2025 | 202 | 0.220 |
Why?
|
| Angioplasty, Balloon | 3 | 2012 | 91 | 0.220 |
Why?
|
| Postoperative Care | 1 | 2006 | 236 | 0.220 |
Why?
|
| Metals | 1 | 2025 | 104 | 0.210 |
Why?
|
| Peripheral Arterial Disease | 1 | 2026 | 110 | 0.210 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 384 | 0.210 |
Why?
|
| Lithotripsy | 1 | 2024 | 42 | 0.210 |
Why?
|
| Treatment Refusal | 1 | 2025 | 69 | 0.210 |
Why?
|
| Intraoperative Complications | 3 | 2010 | 194 | 0.210 |
Why?
|
| Dyslipidemias | 1 | 2025 | 114 | 0.210 |
Why?
|
| Blood Pressure Monitors | 1 | 2004 | 10 | 0.210 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 18 | 0.200 |
Why?
|
| Blood Pressure Determination | 1 | 2004 | 72 | 0.200 |
Why?
|
| Blood Loss, Surgical | 1 | 2025 | 140 | 0.200 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2004 | 20 | 0.200 |
Why?
|
| Comorbidity | 5 | 2020 | 1033 | 0.200 |
Why?
|
| Thrombosis | 2 | 2018 | 318 | 0.200 |
Why?
|
| Blood Transfusion | 1 | 2025 | 180 | 0.200 |
Why?
|
| Thrombolytic Therapy | 2 | 2020 | 259 | 0.200 |
Why?
|
| Europe | 3 | 2020 | 356 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 556 | 0.200 |
Why?
|
| Quality of Life | 1 | 2012 | 1895 | 0.200 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 23 | 0.200 |
Why?
|
| Stress, Mechanical | 2 | 2025 | 251 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2025 | 801 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 266 | 0.190 |
Why?
|
| Arteries | 2 | 2022 | 171 | 0.190 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 251 | 0.190 |
Why?
|
| Hospital Costs | 1 | 2023 | 117 | 0.190 |
Why?
|
| Patient Selection | 2 | 2020 | 726 | 0.190 |
Why?
|
| Ulcer | 2 | 2020 | 38 | 0.180 |
Why?
|
| Radiography | 4 | 2012 | 764 | 0.180 |
Why?
|
| Mentors | 1 | 2023 | 103 | 0.180 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 290 | 0.180 |
Why?
|
| Retreatment | 2 | 2021 | 107 | 0.180 |
Why?
|
| Schools, Medical | 1 | 2023 | 135 | 0.180 |
Why?
|
| Infection Control | 2 | 2020 | 134 | 0.180 |
Why?
|
| Saphenous Vein | 1 | 2021 | 61 | 0.180 |
Why?
|
| Hematoma | 2 | 2020 | 106 | 0.170 |
Why?
|
| Spinal Cord Ischemia | 1 | 2021 | 8 | 0.170 |
Why?
|
| Sex Distribution | 2 | 2020 | 176 | 0.170 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 286 | 0.170 |
Why?
|
| Dilatation | 1 | 2021 | 46 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 663 | 0.170 |
Why?
|
| Students | 1 | 2023 | 196 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 903 | 0.170 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2015 | 8 | 0.160 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 76 | 0.160 |
Why?
|
| Treatment Failure | 2 | 2012 | 300 | 0.160 |
Why?
|
| Phlebography | 2 | 2011 | 74 | 0.160 |
Why?
|
| Intestines | 1 | 2004 | 441 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2023 | 305 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2021 | 174 | 0.160 |
Why?
|
| Intestinal Fistula | 1 | 2020 | 32 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2013 | 250 | 0.160 |
Why?
|
| Clinical Clerkship | 1 | 2021 | 116 | 0.160 |
Why?
|
| Medicare | 1 | 2023 | 467 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2006 | 865 | 0.150 |
Why?
|
| Cysts | 2 | 2015 | 100 | 0.150 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 194 | 0.150 |
Why?
|
| Catheters | 1 | 2020 | 109 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2023 | 283 | 0.150 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 56 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2023 | 850 | 0.150 |
Why?
|
| Health Resources | 1 | 2020 | 80 | 0.150 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 179 | 0.150 |
Why?
|
| Cause of Death | 2 | 2018 | 278 | 0.140 |
Why?
|
| Death Certificates | 1 | 2018 | 11 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2011 | 194 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 231 | 0.140 |
Why?
|
| New Zealand | 1 | 2018 | 24 | 0.140 |
Why?
|
| Device Approval | 1 | 2018 | 15 | 0.140 |
Why?
|
| Brazil | 1 | 2018 | 93 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 580 | 0.140 |
Why?
|
| Australia | 1 | 2018 | 125 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 2013 | 0.130 |
Why?
|
| Thrombectomy | 1 | 2020 | 260 | 0.130 |
Why?
|
| Age Distribution | 1 | 2018 | 208 | 0.130 |
Why?
|
| Diabetic Foot | 1 | 2017 | 16 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 224 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 81 | 0.130 |
Why?
|
| Biomechanical Phenomena | 1 | 2019 | 516 | 0.130 |
Why?
|
| Informed Consent | 1 | 2020 | 284 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 360 | 0.130 |
Why?
|
| General Surgery | 1 | 2020 | 262 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 462 | 0.130 |
Why?
|
| Constriction, Pathologic | 2 | 2010 | 211 | 0.130 |
Why?
|
| Databases, Factual | 2 | 2020 | 1094 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 164 | 0.130 |
Why?
|
| Prospective Studies | 6 | 2026 | 4823 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 169 | 0.120 |
Why?
|
| Adult | 11 | 2024 | 29539 | 0.120 |
Why?
|
| Students, Medical | 1 | 2021 | 449 | 0.120 |
Why?
|
| Obesity | 1 | 2023 | 1061 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 630 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 449 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 47 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2019 | 985 | 0.120 |
Why?
|
| Acute Disease | 3 | 2025 | 860 | 0.110 |
Why?
|
| Goals | 1 | 2015 | 69 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1110 | 0.110 |
Why?
|
| Decision Making | 1 | 2020 | 686 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 157 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 4025 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 916 | 0.100 |
Why?
|
| Propensity Score | 2 | 2025 | 213 | 0.100 |
Why?
|
| Swine | 2 | 2004 | 592 | 0.090 |
Why?
|
| Suture Techniques | 2 | 2024 | 140 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2013 | 282 | 0.090 |
Why?
|
| Vena Cava Filters | 1 | 2013 | 92 | 0.090 |
Why?
|
| Equipment Design | 2 | 2011 | 425 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 2002 | 0.090 |
Why?
|
| Ankle Brachial Index | 1 | 2012 | 29 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 839 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 660 | 0.090 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2011 | 21 | 0.090 |
Why?
|
| Illinois | 1 | 2013 | 522 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 28 | 0.090 |
Why?
|
| Bronchial Fistula | 1 | 2011 | 10 | 0.080 |
Why?
|
| Neck Dissection | 1 | 2011 | 67 | 0.080 |
Why?
|
| National Health Programs | 1 | 2011 | 19 | 0.080 |
Why?
|
| Germany | 1 | 2011 | 84 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1123 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 288 | 0.080 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 46 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2025 | 1147 | 0.080 |
Why?
|
| Thyroidectomy | 1 | 2011 | 181 | 0.080 |
Why?
|
| Pressure | 1 | 2011 | 173 | 0.080 |
Why?
|
| Hypolipidemic Agents | 1 | 2011 | 101 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 3022 | 0.080 |
Why?
|
| Length of Stay | 2 | 2014 | 878 | 0.080 |
Why?
|
| Prevalence | 2 | 2026 | 1384 | 0.070 |
Why?
|
| Triage | 2 | 2020 | 151 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 267 | 0.070 |
Why?
|
| Hospital Mortality | 3 | 2020 | 541 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2009 | 100 | 0.070 |
Why?
|
| Angiography | 2 | 2006 | 194 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 480 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 412 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 101 | 0.060 |
Why?
|
| Adolescent | 4 | 2021 | 10080 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2004 | 2573 | 0.060 |
Why?
|
| Survival Rate | 3 | 2020 | 2041 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2006 | 48 | 0.060 |
Why?
|
| Chicago | 2 | 2020 | 1513 | 0.060 |
Why?
|
| Forecasting | 1 | 2006 | 295 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 219 | 0.050 |
Why?
|
| Syndrome | 1 | 2006 | 438 | 0.050 |
Why?
|
| Hepatic Veins | 1 | 2004 | 27 | 0.050 |
Why?
|
| Calibration | 1 | 2004 | 110 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2006 | 318 | 0.050 |
Why?
|
| Miniaturization | 1 | 2004 | 13 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2024 | 181 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 1536 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2004 | 138 | 0.050 |
Why?
|
| Constriction | 1 | 2003 | 26 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 910 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 107 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2025 | 747 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2003 | 107 | 0.040 |
Why?
|
| Critical Illness | 1 | 2005 | 436 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2023 | 194 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 28 | 0.040 |
Why?
|
| Critical Care | 1 | 2005 | 483 | 0.040 |
Why?
|
| Georgia | 2 | 2011 | 37 | 0.040 |
Why?
|
| Educational Status | 1 | 2021 | 205 | 0.040 |
Why?
|
| Cognition | 1 | 2006 | 673 | 0.040 |
Why?
|
| Calcinosis | 1 | 2002 | 220 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2002 | 279 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 45 | 0.040 |
Why?
|
| Education, Distance | 1 | 2020 | 27 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 81 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 55 | 0.040 |
Why?
|
| Age Factors | 2 | 2020 | 1962 | 0.040 |
Why?
|
| Workload | 1 | 2020 | 130 | 0.040 |
Why?
|
| Biomarkers | 1 | 2026 | 2020 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 103 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 660 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2784 | 0.030 |
Why?
|
| Internet | 1 | 2020 | 358 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 633 | 0.030 |
Why?
|
| Animals | 2 | 2004 | 28904 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 4116 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 7507 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2014 | 381 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2011 | 192 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 215 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2011 | 182 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2010 | 171 | 0.020 |
Why?
|
| Creatinine | 1 | 2009 | 313 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 922 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 3212 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2007 | 161 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 994 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 200 | 0.010 |
Why?
|
| Sutures | 1 | 2006 | 59 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2006 | 119 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2005 | 168 | 0.010 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2005 | 153 | 0.010 |
Why?
|
| Polyesters | 1 | 2003 | 44 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 234 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2004 | 108 | 0.010 |
Why?
|
| Child | 1 | 2015 | 7681 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2004 | 203 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 1751 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 1527 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 193 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 195 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1815 | 0.010 |
Why?
|